Performance of 68Ga-DOTA–conjugated somatostatin receptor–targeting peptide PET in detection of pheochromocytoma and paraganglioma: A systematic review …

S Han, CH Suh, S Woo, YJ Kim… - Journal of Nuclear …, 2019 - Soc Nuclear Med
We performed a systematic review and metaanalysis of the performance of 68Ga-DOTA–
conjugated somatostatin receptor–targeting peptide (68Ga-DOTA-SST) PET in the detection …

Head and neck paragangliomas: an update on the molecular classification, state-of-the-art imaging, and management recommendations

EP Lin, BB Chin, L Fishbein, T Moritani… - Radiology: Imaging …, 2022 - pubs.rsna.org
Paragangliomas are neuroendocrine tumors that derive from paraganglia of the autonomic
nervous system, with the majority of parasympathetic paragangliomas arising in the head …

European association of nuclear medicine practice guideline/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of …

D Taïeb, RJ Hicks, E Hindié, BA Guillet… - European journal of …, 2019 - Springer
Purpose Diverse radionuclide imaging techniques are available for the diagnosis, staging,
and follow-up of phaeochromocytoma and paraganglioma (PPGL). Beyond their ability to …

PET/CT comparing 68Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma …

I Janssen, CC Chen, CM Millo, A Ling, D Taieb… - European journal of …, 2016 - Springer
Abstract Purpose Pheochromocytomas/paragangliomas (PPGLs) and their metastases are
tumors that predominantly express somatostatin receptor 2 (SSR2). 68 Ga-DOTA (0)-Tyr (3) …

68Ga-DOTATATE PET/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT/MRI

I Janssen, CC Chen, D Taieb, NJ Patronas… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Pheochromocytomas/paragangliomas overexpress somatostatin receptors, and recent
studies have already shown excellent results in the localization of sympathetic succinate …

Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment

VL Martucci, K Pacak - Current problems in cancer, 2014 - Elsevier
Pheochromocytomas (PHEOs) are rare neuroendocrine tumors that arise from the
chromaffin cells of the adrenal glands. Paragangliomas (PGLs), the extra-adrenal …

[HTML][HTML] Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups

D Taïeb, A Jha, G Treglia… - Endocrine-related cancer, 2019 - erc.bioscientifica.com
In recent years, advancement in genetics has profoundly helped to gain a more
comprehensive molecular, pathogenic, and prognostic picture of pheochromocytomas and …

Current approaches and recent developments in the management of head and neck paragangliomas

D Taïeb, A Kaliski, CC Boedeker, V Martucci… - Endocrine …, 2014 - academic.oup.com
Head and neck paragangliomas (HNPGLs) are rare neuroendocrine tumors belonging to
the family of pheochromocytoma/paraganglioma neoplasms. Despite advances in …

Prospective comparison of 68Ga-DOTATATE and 18F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic …

A Archier, A Varoquaux, P Garrigue, M Montava… - European journal of …, 2016 - Springer
Abstract Purpose Pheochromocytomas/paragangliomas (PHEOs/PGLs) overexpress
somatostatin receptors and recent studies have already shown excellent results in the …

Paragangliomas of the head and neck

S Woolen, JJ Gemmete - Neuroimaging Clinics, 2016 - neuroimaging.theclinics.com
Paragangliomas make up a family of neoplasms that develop from the paraganglia tissues,
which are themselves of neural crest origin and have similar functions and histologic …